A Nutritional Approach to Minimal Hepatic Encephalopathy
NCT01083446 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2010-03-09
Summary
This trial will study a possible effect of standard Israeli breakfast (30% of caloric value and 21 gram protein) on cognitive and executive functions (working memory, visual memory, concentration and coordination), on patients with mild-moderate liver cirrhosis.
Conditions
- Minimal Hepatic Encephalopathy
Interventions
- OTHER
-
Nutritional Intervention
Cognitive and executive functions before and after standard israeli breakfast (30% of caloric value and 21 gram protein)
- OTHER
-
Nutritional Intervention
Cognitive and executive functions during fast
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Principal Investigators
-
Nachum Vaisman, Prof' · Tel-Aviv Sourasky Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Exploratory Trial in Healthy Adults With Mild Cognitive Impairment,16-week Intervention With Mitocholine™
NCT05690724 ·Status: COMPLETED ·Phase: NA
-
Network-Level Mechanisms for Preclinical Alzheimer's Disease Development
NCT03461861 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
NCT06114745 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
NCT02957682 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00605059 ·Status: TERMINATED ·Phase: PHASE1
-
The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment
NCT00736034 ·Status: COMPLETED ·Phase: PHASE4
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy of Cognitex
NCT00719953 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome
NCT02535611 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI
NCT07287852 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition
NCT00968097 ·Status: TERMINATED ·Phase: PHASE1
-
Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)
NCT01044758 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
NCT01082965 ·Status: TERMINATED ·Phase: NA
-
Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects
NCT02616445 ·Status: COMPLETED ·Phase: PHASE1
-
MemoryXL Effects on Mild Cognitive Impairment Patients
NCT00903695 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
NCT00862940 ·Status: COMPLETED ·Phase: PHASE4
-
A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition
NCT01044342 ·Status: COMPLETED ·Phase: PHASE1
-
Lifestyle Intervention Program for Cognitive Impairment
NCT02741804 ·Status: UNKNOWN ·Phase: NA
-
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
NCT00842673 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury
NCT06337994 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial
NCT04147624 ·Status: COMPLETED ·Phase: PHASE2
-
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
NCT01741194 ·Status: COMPLETED ·Phase: PHASE2/PHASE3